SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
EntreMed (ENMD)
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
2135 59 0 ENMD
Emcee:  Mark Wise Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
510 What Entremed has discovered is nothing new. A drug called Thalidomide which hTom R. Clarksburg-5/4/1998
509 Charles Sims, If you worked with Dr. Folkman, how come you referred to the Drzebraspot-5/4/1998
508 >If it works try over $5000 next year. you are forgetting one thing, if itOtherChap-5/4/1998
507 Stock Doc, """If the drug works in man as preliminary clinical Cosmo Daisey-5/4/1998
506 The drug could be a home run...but getting the drug to the tumor could prove dVulture-5/4/1998
505 Dave- Get real.... until this is proven in human clinicals... its a maybe at bTech Master-5/4/1998
504 < it should be above 100 next year.> You must be mad. Tell us which druHaolin Ni-5/4/1998
503 Is it true that ENMD is working under contract for Bristol Meyers and that BMY jjs_ynot-5/4/1998
502 Absolutely, you beat me to it. ENMD has a number of other drugs in the pipelinDavid Winkler-5/4/1998
501 If the drug works in man as preliminary clinical data now suggest (it's comStockDoc-5/4/1998
500 There is a huge difference between GERN and ENMD. I think today's trading Tummus1-5/4/1998
499 The fundamental haven't changed... just the coverage. we are seeing a niceTech Master-5/4/1998
498 Tech Master, Are you implying that Blair engineered the publicity campaign. IfSam Citron-5/4/1998
497 Off topic--old news, but something to look at. Post on SI (DYGND) DynaGen Receesterina-5/4/1998
496 The patent was filed in Europe, hence the abstract got published (even though iStockDoc-5/4/1998
495 ENMD will be less than $20 after one year. Look at the GERN, Two papers publisHaolin Ni-5/4/1998
494 Marty- I just put both those companies on my radar. FWIW- look at CGLB... useTech Master-5/4/1998
493 hahaha, it is too good to be true! Mike Thompson-5/4/1998
492 Anyone care to make a prediction of the price a year from now? Congrats to alljaci hartman-5/4/1998
491 More likely if you placed a market order for your calls you would have been broJeffrey S. Mitchell-5/4/1998
490 >>I predict a pop of 1 - 2 points on Monday Try 73-74 point pop !!!!!!!Jimbo Cobb-5/4/1998
489 This is the pause before the fall again... there is no new news... this is GeroTech Master-5/4/1998
488 I don't think you missed an easy $1,000,000 Buendia-- the options prices yoMonir Mamoun-5/4/1998
487 MAGN is another serious anti-angiogenesis player. At $6, I think the stock is oBulbaMan-5/4/1998
486 Listen to this. I read the article and last night put in an order for 120 May Buendia-5/4/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News